The Benefit-Harm Frontier of Different Primary Screening Strategies for Cervical Cancer in Germany

Sroczynski G, Esteban E, Engel J, Hillemanns P, Petry K-U, Krämer A, Schnell-Inderst P, Muehlberger N, Siebert U (2013)
Value in Health 16(7): A574-A575.

Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Kurzbeitrag Konferenz | Veröffentlicht | Englisch
Autor
; ; ; ; ; ; ; ;
Erscheinungsjahr
Band
16
Zeitschriftennummer
7
Seite
A574-A575
ISSN
PUB-ID

Zitieren

Sroczynski G, Esteban E, Engel J, et al. The Benefit-Harm Frontier of Different Primary Screening Strategies for Cervical Cancer in Germany. Value in Health. 2013;16(7):A574-A575.
Sroczynski, G., Esteban, E., Engel, J., Hillemanns, P., Petry, K. - U., Krämer, A., Schnell-Inderst, P., et al. (2013). The Benefit-Harm Frontier of Different Primary Screening Strategies for Cervical Cancer in Germany. Value in Health, 16(7), A574-A575.
Sroczynski, G., Esteban, E., Engel, J., Hillemanns, P., Petry, K. - U., Krämer, A., Schnell-Inderst, P., Muehlberger, N., and Siebert, U. (2013). The Benefit-Harm Frontier of Different Primary Screening Strategies for Cervical Cancer in Germany. Value in Health 16, A574-A575.
Sroczynski, G., et al., 2013. The Benefit-Harm Frontier of Different Primary Screening Strategies for Cervical Cancer in Germany. Value in Health, 16(7), p A574-A575.
G. Sroczynski, et al., “The Benefit-Harm Frontier of Different Primary Screening Strategies for Cervical Cancer in Germany”, Value in Health, vol. 16, 2013, pp. A574-A575.
Sroczynski, G., Esteban, E., Engel, J., Hillemanns, P., Petry, K.-U., Krämer, A., Schnell-Inderst, P., Muehlberger, N., Siebert, U.: The Benefit-Harm Frontier of Different Primary Screening Strategies for Cervical Cancer in Germany. Value in Health. 16, A574-A575 (2013).
Sroczynski, G., Esteban, E., Engel, J., Hillemanns, P., Petry, K. -U, Krämer, Alexander, Schnell-Inderst, P., Muehlberger, N., and Siebert, U. “The Benefit-Harm Frontier of Different Primary Screening Strategies for Cervical Cancer in Germany”. Value in Health 16.7 (2013): A574-A575.